{"count": 7, "results": [{"_id": "31772118", "pmid": 31772118, "title": "Metformin in Gynecologic Cancers: Opening a New Window for Prevention and Treatment?", "journal": "Clin Cancer Res", "authors": ["Madariaga A", "Goodwin PJ", "Oza AM"], "date": "2020-02-01T00:00:00Z", "doi": "10.1158/1078-0432.CCR-19-3645", "meta_date_publication": "2020 Feb 1", "meta_volume": "26", "meta_issue": "3", "meta_pages": "523-525", "score": 50260.54, "text_hl": "Potential anticancer effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Genital_Neoplasms_Female</m> @DISEASE_MESH:D005833 @@@gynecologic malignancies@@@ include inhibition of the PI3K-@GENE_MTOR @GENE_2475 @@@mTOR@@@ pathway, hormone receptor regulation, and reduction of @DISEASE_Fibrosis @DISEASE_MESH:D005355 @@@fibrosis@@@ and @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@. ", "citations": {"NLM": "Madariaga A, Goodwin PJ, Oza AM. Metformin in Gynecologic Cancers: Opening a New Window for Prevention and Treatment? Clin Cancer Res. 2020 Feb 1;26(3):523-525. PMID: 31772118", "BibTeX": "@article{31772118, title={Metformin in Gynecologic Cancers: Opening a New Window for Prevention and Treatment?}, author={Madariaga A and Goodwin PJ and Oza AM}, journal={Clin Cancer Res}, volume={26}, number={3}, pages={523-525}}"}}, {"_id": "35326656", "pmid": 35326656, "pmcid": "PMC8946838", "title": "Divergent Metabolic Effects of Metformin Merge to Enhance Eicosapentaenoic Acid Metabolism and Inhibit Ovarian Cancer In Vivo", "journal": "Cancers (Basel)", "authors": ["Udumula MP", "Poisson LM", "Dutta I", "Tiwari N", "Kim S", "Chinna-Shankar J", "Allo G", "Sakr S", "Hijaz M", "Munkarah AR", "Giri S", "Rattan R"], "date": "2022-03-15T00:00:00Z", "doi": "10.3390/cancers14061504", "meta_date_publication": "2022 Mar 15", "meta_volume": "14", "meta_issue": "6", "meta_pages": "", "score": 50251.38, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ is being actively repurposed for the treatment of @<m>DISEASE_Genital_Neoplasms_Female</m> @DISEASE_MESH:D005833 @@@gynecologic malignancies@@@ including @DISEASE_Ovarian_Neoplasms @DISEASE_MESH:D010051 @@@ovarian cancer@@@. ", "citations": {"NLM": "Udumula MP, Poisson LM, Dutta I, Tiwari N, Kim S, Chinna-Shankar J, Allo G, Sakr S, Hijaz M, Munkarah AR, Giri S, Rattan R. Divergent Metabolic Effects of Metformin Merge to Enhance Eicosapentaenoic Acid Metabolism and Inhibit Ovarian Cancer In Vivo Cancers (Basel). 2022 Mar 15;14(6):. PMID: 35326656", "BibTeX": "@article{35326656, title={Divergent Metabolic Effects of Metformin Merge to Enhance Eicosapentaenoic Acid Metabolism and Inhibit Ovarian Cancer In Vivo}, author={Udumula MP and Poisson LM and Dutta I and Tiwari N and Kim S and Chinna-Shankar J and Allo G and Sakr S and Hijaz M and Munkarah AR and Giri S and Rattan R}, journal={Cancers (Basel)}, volume={14}, number={6}}"}}, {"_id": "23879009", "pmid": 23879009, "title": "[Metformin--new treatment strategies for gynecologic neoplasms].", "journal": "Przegl Lek", "authors": ["Milewicz T", "Kiałka M", "Mrozińska S", "Ociepka A", "Krzysiek J"], "date": "2013-01-01T00:00:00Z", "meta_date_publication": "2013", "meta_volume": "70", "meta_issue": "2", "meta_pages": "81-4", "score": 50084.695, "text_hl": "[@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@--new treatment strategies for @<m>DISEASE_Genital_Neoplasms_Female</m> @DISEASE_MESH:D005833 @@@gynecologic neoplasms@@@].", "citations": {"NLM": "Milewicz T, Kiałka M, Mrozińska S, Ociepka A, Krzysiek J. [Metformin--new treatment strategies for gynecologic neoplasms]. Przegl Lek. 2013;70(2):81-4. PMID: 23879009", "BibTeX": "@article{23879009, title={[Metformin--new treatment strategies for gynecologic neoplasms].}, author={Milewicz T and Kiałka M and Mrozińska S and Ociepka A and Krzysiek J}, journal={Przegl Lek}, volume={70}, number={2}, pages={81-4}}"}}, {"_id": "26893732", "pmid": 26893732, "title": "Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning.", "journal": "Oncol Lett", "authors": ["Irie H", "Banno K", "Yanokura M", "Iida M", "Adachi M", "Nakamura K", "Umene K", "Nogami Y", "Masuda K", "Kobayashi Y", "Tominaga E", "Aoki D"], "date": "2016-02-01T00:00:00Z", "doi": "10.3892/ol.2016.4075", "meta_date_publication": "2016 Feb", "meta_volume": "11", "meta_issue": "2", "meta_pages": "1287-1293", "score": 50079.457, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@: A candidate for the treatment of @<m>DISEASE_Genital_Neoplasms_Female</m> @DISEASE_MESH:D005833 @@@gynecological tumors@@@ based on drug repositioning.", "citations": {"NLM": "Irie H, Banno K, Yanokura M, Iida M, Adachi M, Nakamura K, Umene K, Nogami Y, Masuda K, Kobayashi Y, Tominaga E, Aoki D. Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning. Oncol Lett. 2016 Feb;11(2):1287-1293. PMID: 26893732", "BibTeX": "@article{26893732, title={Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning.}, author={Irie H and Banno K and Yanokura M and Iida M and Adachi M and Nakamura K and Umene K and Nogami Y and Masuda K and Kobayashi Y and Tominaga E and Aoki D}, journal={Oncol Lett}, volume={11}, number={2}, pages={1287-1293}}"}}, {"_id": "25144611", "pmid": 25144611, "title": "Metformin and gynecologic cancers.", "journal": "Obstet Gynecol Surv", "authors": ["Stine JE", "Bae-Jump V"], "date": "2014-08-01T00:00:00Z", "doi": "10.1097/OGX.0000000000000092", "meta_date_publication": "2014 Aug", "meta_volume": "69", "meta_issue": "8", "meta_pages": "477-89", "score": 50060.11, "text_hl": "On the basis of these data, centers are currently enrolling for clinical trials using @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @SPECIES_9606 @@@patients@@@ diagnosed with @<m>DISEASE_Genital_Neoplasms_Female</m> @DISEASE_MESH:D005833 @@@gynecologic malignancies@@@. ", "citations": {"NLM": "Stine JE, Bae-Jump V. Metformin and gynecologic cancers. Obstet Gynecol Surv. 2014 Aug;69(8):477-89. PMID: 25144611", "BibTeX": "@article{25144611, title={Metformin and gynecologic cancers.}, author={Stine JE and Bae-Jump V}, journal={Obstet Gynecol Surv}, volume={69}, number={8}, pages={477-89}}"}}, {"_id": "25455733", "pmid": 25455733, "title": "Old drug, new trick: repurposing metformin for gynecologic cancers?", "journal": "Gynecol Oncol", "authors": ["Febbraro T", "Lengyel E", "Romero IL"], "date": "2014-12-01T00:00:00Z", "doi": "10.1016/j.ygyno.2014.10.011", "meta_date_publication": "2014 Dec", "meta_volume": "135", "meta_issue": "3", "meta_pages": "614-21", "score": 50051.06, "text_hl": "Until this question is answered with prospective clinical testing, the role of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in the treatment or prevention of @<m>DISEASE_Genital_Neoplasms_Female</m> @DISEASE_MESH:D005833 @@@gynecologic malignancies@@@ remains theoretical and the clinical use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as a @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ therapeutic is experimental.", "citations": {"NLM": "Febbraro T, Lengyel E, Romero IL. Old drug, new trick: repurposing metformin for gynecologic cancers? Gynecol Oncol. 2014 Dec;135(3):614-21. PMID: 25455733", "BibTeX": "@article{25455733, title={Old drug, new trick: repurposing metformin for gynecologic cancers?}, author={Febbraro T and Lengyel E and Romero IL}, journal={Gynecol Oncol}, volume={135}, number={3}, pages={614-21}}"}}, {"_id": "31009857", "pmid": 31009857, "title": "The association between metformin therapy and risk of gynecological cancer in patients: Two meta-analyses.", "journal": "Eur J Obstet Gynecol Reprod Biol", "authors": ["Wen Q", "Zhao Z", "Wen J", "Zhou J", "Wu J", "Lei S", "Miao Y"], "date": "2019-06-01T00:00:00Z", "doi": "10.1016/j.ejogrb.2019.03.029", "meta_date_publication": "2019 Jun", "meta_volume": "237", "meta_issue": "", "meta_pages": "33-41", "score": 50047.28, "text_hl": "BACKGROUND: Recently, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, first-line drug for @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@, has been reported to treat some @<m>DISEASE_Genital_Neoplasms_Female</m> @DISEASE_MESH:D005833 @@@gynecological tumors@@@. ", "citations": {"NLM": "Wen Q, Zhao Z, Wen J, Zhou J, Wu J, Lei S, Miao Y. The association between metformin therapy and risk of gynecological cancer in patients: Two meta-analyses. Eur J Obstet Gynecol Reprod Biol. 2019 Jun;237():33-41. PMID: 31009857", "BibTeX": "@article{31009857, title={The association between metformin therapy and risk of gynecological cancer in patients: Two meta-analyses.}, author={Wen Q and Zhao Z and Wen J and Zhou J and Wu J and Lei S and Miao Y}, journal={Eur J Obstet Gynecol Reprod Biol}, volume={237}, pages={33-41}}"}}]}